Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT00150215
Show Display Options
Rank Status Study
1 Completed A First In Human Study Of PF-00184562 In Healthy Volunteers
Condition: Schizophrenia
Interventions: Drug: PF-00184562;   Drug: Olanzapine

Indicates status has not been verified in more than two years